ANN ARBOR STAGE II DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for ANN ARBOR STAGE II DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE II DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE II DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive lymphoma: targeted drug combo shows promise
Disease control OngoingThis study tests a new drug called parsaclisib added to standard chemotherapy (R-CHOP) for people with newly diagnosed, high-risk diffuse large B-cell lymphoma. The goal is to find the best dose and see if the combination is safe and works better than standard treatment alone. Ab…
Matched conditions: ANN ARBOR STAGE II DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 10:26 UTC
-
New hope for HIV patients with aggressive lymphoma?
Disease control OngoingThis early-stage trial tested a combination of the targeted drug ibrutinib with standard chemotherapy (R-da-EPOCH) in 46 HIV-positive people with a type of lymphoma called diffuse large B-cell lymphoma. The main goals were to find the safest dose and check for side effects. The s…
Matched conditions: ANN ARBOR STAGE II DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New combo shows promise in fighting aggressive blood cancer
Disease control OngoingThis study compares two treatments for people newly diagnosed with a fast-growing type of lymphoma (diffuse large B-cell lymphoma). One group gets standard chemo plus a targeted drug, while the other gets the same chemo with an added immune-boosting drug. The goal is to see if th…
Matched conditions: ANN ARBOR STAGE II DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 04, 2026 16:30 UTC